Preclinical and clinical evidence for the role of resveratrol in the treatment of cardiovascular diseases
Top Cited Papers
- 1 June 2015
- journal article
- review article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1852 (6) , 1155-1177
Abstract
No abstract availableKeywords
Funding Information
- Canadian Institutes of Health Research (CIHR)
This publication has 298 references indexed in Scilit:
- Grape Resveratrol Increases Serum Adiponectin and Downregulates Inflammatory Genes in Peripheral Blood Mononuclear Cells: A Triple-Blind, Placebo-Controlled, One-Year Clinical Trial in Patients with Stable Coronary Artery DiseaseCardiovascular Drugs and Therapy, 2012
- SIRT1 Is Required for AMPK Activation and the Beneficial Effects of Resveratrol on Mitochondrial FunctionCell Metabolism, 2012
- Resveratrol Ameliorates Aging-Related Metabolic Phenotypes by Inhibiting cAMP PhosphodiesterasesCell, 2012
- Resveratrol inhibits migration and Rac1 activation in EGF‐ but not PDGF‐activated vascular smooth muscle cellsMolecular Nutrition & Food Research, 2011
- SIRT1 regulates oxidant- and cigarette smoke-induced eNOS acetylation in endothelial cells: Role of resveratrolBiochemical and Biophysical Research Communications, 2010
- Resveratrol Delays Age-Related Deterioration and Mimics Transcriptional Aspects of Dietary Restriction without Extending Life SpanCell Metabolism, 2008
- Resveratrol protects ROS-induced cell death by activating AMPK in H9c2 cardiac muscle cellsGenes & Nutrition, 2007
- Resveratrol alleviates cardiac dysfunction in streptozotocin-induced diabetes: Role of nitric oxide, thioredoxin, and heme oxygenaseFree Radical Biology and Medicine, 2007
- AKT/PKB Signaling: Navigating DownstreamCell, 2007
- Quantitation of trans-resveratrol and detection of its metabolites in human plasma and urine by high performance liquid chromatographyJournal of Chromatography B, 2007